Marpai, Inc. (MRAI) stock
Close on Oct 19, 2026Market cap $85.32MP/E –Yield –
Marpai, Inc. saw revenue fall 17.8% to $17.02M over the twelve months to Sep 30, 2026. At the latest close the market valued the company at $85.32M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $85.32M
- P/E ratio
- –
- Price to sales
- 5.01
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $17.02M
- Net income
- -$16.68M
- EPS, diluted
- -$0.70
- Book value per share
- -$1.11
- Diluted shares
- 27M
Trading
- Previous close
- $3.13
- Open
- $3.20
- Day's range
- $3.15 – $3.33
- Volume
- 9,921
- Average volume (20 days)
- 18,667
Market cap history
Month-end market cap since 2021, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | MRAI | S&P 500 | Difference | MRAI per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -1.2% | +0.6% | −1.9 pts | ||
| 3 months | +92.7% | +3.4% | +89.4 pts | ||
| Year to date | +404.0% | +13.3% | +390.7 pts | ||
| 1 year | +112.0% | +16.6% | +95.4 pts | ||
| 3 years | +486.7% | +86.4% | +400.3 pts | +80.4% | +23.1% |
Seven years at a glance
Fiscal years 2019 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Marpai filed with the SEC as exhibits to Form 8-K or 6-K
- News
- News
- Results
- Results
- Results
- News
About Marpai
Services-Misc Health & Allied Services, NEC
Marpai, Inc. is a healthcare technology platform company operating subsidiaries that provide third-party administrator and pharmacy benefit management services. The business serves self-insured employers who directly fund employee healthcare programs, with a client base primarily comprising small and medium-sized enterprises as well as local government entities. Its activities span three main revenue streams: health plan administration, in-house ancillary offerings, and third-party vendor services. These solutions include custom benefit plan design, claims adjudication, clinical care navigation, out-of-network claims repricing, specialty drug savings, and comprehensive pharmacy benefit management.
Company profile, executives and historyMarpai stock: common questions
What is Marpai's stock price?
MRAI closed at $3.18 on Oct 19, 2026, up 1.60% on the day.
What is Marpai's market cap?
Marpai was worth $85.32M at the close on Oct 19, 2026: the share price times the diluted shares outstanding.
What is MRAI's P/E ratio?
Marpai lost money over the twelve months to Sep 30, 2026 (diluted EPS -$0.70), so it has no meaningful P/E ratio.
How much revenue does Marpai make?
Marpai reported revenue of $17.02M for the twelve months to Sep 30, 2026, down 17.8% from a year earlier.
Does Marpai pay a dividend?
No. Marpai has not paid a cash dividend over the last twelve months.
How has MRAI stock performed over the past year?
Including dividends, MRAI returned +112.0% over the past year, against +16.6% for the S&P 500.
Who are Marpai's competitors?
Companies most similar to Marpai by business, industry and size include NIVF, PFHO, CCEL, MCTA, EHSI.
See a number that looks wrong?